We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Smoking Promotes Rapid Cognitive Decline

By HospiMedica International staff writers
Posted on 27 Feb 2012
Middle-age male smokers endure the equivalent of an extra ten years of aging on their global cognition and executive function, according to a new study.

Researchers at University College London (UCL; United Kingdom) conducted a cohort study involving 5,099 men and 2,137 women (mean age 56 years) participating in the Whitehall II study to examine the association between smoking history and cognitive decline in the transition from midlife to old age. More...
The assessment included a cognitive test battery composed of memory, vocabulary, executive function (composed of one reasoning and two fluency tests), and a global cognitive score summarizing performance across all five tests. The first cognitive assessment was in 1997-1999, repeated in 2002-2004 and then in 2007-2009. The main outcome measure was the association between smoking history and 10-year cognitive decline.

The results showed faster cognitive and executive function decline among male current smokers, when compared to never smokers. Recent ex-smokers had greater decline in executive function, while the decline in long-term ex-smokers was similar to that among never smokers. The 10-year cognitive decline (in all tests except vocabulary) among the never smokers ranged from a quarter to a third than that of the smokers. When taking into account dropout and death, these differences were 1.2-1.5 times larger. In women, however, cognitive decline did not vary as a function of smoking status. The study was published early online on February 6, 2012, in the Archives of General Psychiatry.

“While we were aware that smoking is a risk factor for respiratory disease, cancer, and cardiovascular disease, this study shows it also has a detrimental effect on cognitive ageing and this is evident as early as 45 years,” said lead author Séverine Sabia, PhD, of the UCL department of epidemiology and public health. “A 50 year old male smoker shows a similar cognitive decline as a 60 year old male never smoker.”

Related Links:

University College London




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.